Search

Displaying results 8851 - 8860 of 10000 in total
  1. Drug

    Simtuzumab

    go.drugbank.com/drugs/DB12152
    Investigational

    Simtuzumab has been used in trials studying the treatment and basic science of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.

  2. Drug

    TAK-733

    go.drugbank.com/drugs/DB12241
    Investigational

    TAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies.

  3. Drug

    Taladegib

    go.drugbank.com/drugs/DB12550
    Investigational

    Taladegib has been used in trials studying the treatment of Solid Tumor, COLON CANCER, BREAST CANCER, Advanced Cancer, and Rhabdomyosarcoma, among others.

  4. Drug

    Fluocinolone

    go.drugbank.com/drugs/DB12553
    Investigational

    Fluocinolone has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Choroidal Neovascularization.

  5. Drug

    Samatasvir

    go.drugbank.com/drugs/DB12660
    Investigational

    Samatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.

  6. Drug

    Naptumomab estafenatox

    go.drugbank.com/drugs/DB12807
    Investigational

    Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.

  7. Drug

    Pyroxamide

    go.drugbank.com/drugs/DB12847
    Investigational

    Pyroxamide has been used in trials studying the treatment of Leukemia, Lymphoma, Small Intestine Cancer, Precancerous Condition, and Myelodysplastic Syndromes, among others.

  8. Drug

    Ombrabulin

    go.drugbank.com/drugs/DB12882
    Investigational

    Ombrabulin has been used in trials studying the treatment of Sarcoma, Neoplasms, Solid Tumor, Neoplasms, Malignant, and Advanced Solid Tumors, among others.

  9. Drug

    Samarium Sm-153

    go.drugbank.com/drugs/DB12905
    Investigational

    Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer.

  10. Drug

    REP8839

    go.drugbank.com/drugs/DB05224
    Experimental

    REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).